Positive proof-of-concept experiments may lead to the world’s first treatment for celiac disease

An investigational treatment for celiac disease effectively controls the condition—at least in an animal model—in a first-of-its-kind therapeutic for a condition that affects approximately 70 million people worldwide.

Leave A Comment

Your email address will not be published. Required fields are marked *